WASHINGTON—The Food and Drug Administration ordered stronger warnings Thursday on four medications widely used to treat rheumatoid arthritis and other serious illnesses, saying they can raise the risk of possibly fatal fungal infections. The drugs -- Enbrel, Remicade, Humira and Cimzia -- work by suppressing the immune system to keep it from attacking the body. For patients with rheumatoid arthritis, the treatment provides relief from swollen and painful joints, but it's "a double-edged sword," said the FDA's Dr. Jeffrey Siegel. That's...
New Data Shows Breakthrough microRNA-Targeted Therapy Developed Using Santaris Pharma A/S Proprietary LNA Technology Holds Promise as New Treatment for Hepatitis C
PR Newswire
PR Newswire
Download image...
Health Protection Agency issues an alert to drug users after a heroin user in London ...
The Daily Mail
The Daily Mail
How antiviral drugs block flu virus
Newstrack India
Newstrack India
London, Feb 4 (ANI): Scientists at Iowa State University have identified the mechanism through which antiviral drugs block influenza A. The study showed that these drugs block influenza A viruses from reproducing...
GeoVax Labs, Inc. Begins Enrollment at Final Site for Preventative Vaccine; Next Step Is to Submit IND Application for Therapeutic Vaccine to FDA
PR Newswire
PR Newswire
Hires Clinical Research Organization ATLANTA, Feb. 8 /PRNewswire-FirstCall/ -- GeoVax Labs, Inc. (OTC Bulletin Board: GOVX) (the "Company"), an Atlanta-based, biopharmaceutical company developing human vaccines...
"Awareness needed on transmission of Hepatitis-C Virus"
The Hindu
The Hindu
Special Correspondent Preceptorship Programme for gastroenterologists held...
FDA Seeks More Data for Theravance Drug
ABC News
ABC News
SOUTH SAN FRANCISCO, Calif. January 28, 2010 (AP) The Associated Press Theravance Inc. said Thursday regulators are not satisfied with its data to back a second use for its infection drug Vibativ, and the drug developer...

